17/12/2024 - Press release
Phase 1/2 of the clinical trial shows that the administration of the AEF0217 molecule developed by the biotech Aelis Farma, is safe and can improve key skills such as communication, social interactions and daily living for people with Down syndrome These results reinforce the start of the phase 2 clinical trial, through an international multicenter study with people with Down syndrome, focused on the dose necessary to achieve the treatment goal
16/12/2024 - Institutional news
The work of the Catalonia Anti-Doping Laboratory in the field of innovation and research has been recognized by the Catalan Sports Foundation at the eighth edition of the Sports Awards. The award highlighted the laboratory's research and innovation activities for clean sport, which have earned international recognition. A delegation led by Rosa Ventura, the laboratory's director, and five team members-Sergi Coll, Imma Figuera, Lídia Requena, Susana Cuadras, and Claudia Bressan-attended the award ceremony.
22/11/2024 - General information
This project will study the short- and long-term impact of steroid sulfation, which is involved in various biological processes, during pregnancy and its influence on maternal mental health and the mother-child bond. The project, "Short- and Long-term Effects of Steroid Sulfation During Pregnancy on Brain Plasticity, Maternal Well-being, and the Mother-Child Bond", led by Dr. Òscar Vilarroya, coordinator of the Neuroimaging of Mental Disorders Research Group at the Hospital del Mar Research Institute, will receive funding from La Marató de TV3 and Catalunya Ràdio. It is one of 26 projects related to sexual and reproductive health selected by the Board of Trustees of La Marató Foundation upon the recommendation of the Advisory Commission. Over 100 proposals were submitted in this edition.
20/11/2024 - General information
The project has received one of the recognitions in the Responsible Research and Innovation in Health awards. The award highlights the added value of the project for incorporating public participation in its design. The PENSA study aims to contribute to the research of effective treatments to prevent or delay dementia.
13/11/2024 - Press release
Conversely, women tolerate it better than men, according to a multicenter study led by Hospital del Mar and its research institute, published in the Journal of Cardiothoracic and Vascular Anesthesia. The study analyzed the outcomes of more than 200 people who underwent a thoracotomy, a type of open surgery that requires separating the ribs to reach the lungs. The differences between men and women are not due to physiological or genetic factors but to a worse initial situation for women regarding their quality of life prior to surgery. The researchers highlight the need to consider this and introduce the idea of addressing psychological components before surgery as part of a personalized approach to pain management.
Més informació "They demonstrate that women suffer more chronic postoperative pain than men"
30/07/2024 - Institutional news
Dr. Arnau Busquets, coordinator of the Research Group on Cellular Mechanisms in Physiological and Pathological Behavior at the Hospital del Mar Research Institute, has been selected in the Leonardo grants to support science and culture of excellence, awarded by the BBVA Foundation. In total, 58 projects have been selected, 18 of which in Catalonia. The project led by Dr. Busquets, 'Identifying brain circuits involved in emotional recognition', has been one of the six winners in this edition in the category of Biology and Biomedicine. The aim of the project is to identify the specific brain circuits involved in empathy processes that may be involved in complex social deficits observed in some neurodevelopmental disorders or neurodegenerative diseases. To identify them, a specific mouse model and pharmacogenetic techniques will be used.
Més informació "The BBVA Foundation awards one of its Leonardo grants to Dr. Arnau Busquets."
24/05/2024 - General information
Dr. Marta Torrens, Emeritus Director of Addictions of the Mental Health Institute of the Hospital del Mar and researcher of her research institute, has been selected by the executive committee of the European Union Drugs Agency (EUDA), to be part of its scientific committee. The decision was made on July 4 and Dr. Torrens will be one of the agency's advisors for the next four years. The European Union Agency for Drugs and Drug Addiction is the successor of the former European Monitoring Centre for Drugs and Drug Addiction, with enhanced capabilities and responsibilities.
18/07/2024 - General information
The Hospital del Mar Research Institute will be Olympic again. Three of the professionals of the Institute's Anti-Doping Laboratory of Catalonia will work in the Olympic Laboratory during the Olympic and Paralympic Games in Paris. They are Sergi Coll and Lídia Requena, who will travel to Paris to work at the Laboratory from July 26 to August 11 during the Olympic Games, and Indira Anselmo, who will work from August 28 to September 8, during the Paralympic Games. Sergi Coll is a specialist in the detection of anabolic steroids, and Lídia Requena and Indira Anselmo are specialists in the detection of hormones (erythropoietin, growth hormone...) and blood transfusions.
29/05/2024 - Press release
An international study led by the Hospital del Mar Medical Research Institute has demonstrated, for the first time, the role of two proteins in the activation and deactivation of the system through which drugs act against schizophrenia symptoms. These two proteins are potential targets for developing new drugs aimed at specific symptoms of the disease, avoiding the side effects of current treatments. The study analyzed how certain molecules act on a serotonin cell receptor, which could allow for differentiated effects on schizophrenia symptoms without affecting other brain processes.
Més informació "New Avenues to Developing Personalized Treatments for Schizophrenia"
30/04/2024 - Institutional news
Researchers from the Neuroscience Research Program, in conjunction with the University of Minnesota in the United States, will conduct the first meta-analysis with individual data on this issue. They will analyze data from more than 30,000 people in the United States and four European countries. The aim is to obtain recommendations so that governments can establish dietary guidelines to prevent the onset of diseases such as Alzheimer's disease. Is there any type of diet that really works to prevent cognitive decline? Despite all the publications on this question, the scientific evidence is not conclusive. For this reason, the Institute for the Advancement of Foord and Nutrition Sciences (IAFNS), in the United States, a body that acts as an advisor to the US government, has commissioned the Hospital del Mar Research Institute and the Epidemiology and Community Health Division of the University of Minnesota School of Public Health to conduct the first meta-analysis with individual data on the question.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
